Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Ensem Therapeutics
PMV Pharmaceuticals, Inc
Tubulis GmbH
Eli Lilly and Company
Kidney Cancer Research Bureau
Second Life Therapeutics
Onchilles Pharma Inc
Eli Lilly and Company
BicycleTx Limited
Eli Lilly and Company
ITM Oncologics GmbH
Maastricht University Medical Center
LigaChem Biosciences, Inc.
Bolt Biotherapeutics, Inc.
Palleon Pharmaceuticals, Inc.
ModeX Therapeutics, An OPKO Health Company
Intensity Therapeutics, Inc.
BioAtla, Inc.
UNICANCER
Cyteir Therapeutics, Inc.
Aminex Therapeutics, Inc.
Second Affiliated Hospital of Guangzhou Medical University
Innolake Biopharm
GeneMedicine Co., Ltd.
CytomX Therapeutics
Klus Pharma Inc.
Kineta Inc.
Incyte Corporation
Petra Pharma
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center